Skip to Content


In the US, Hivid (zalcitabine systemic) is a member of the drug class nucleoside reverse transcriptase inhibitors (NRTIs) and is used to treat HIV Infection.

US matches:

Ingredient matches for Hivid


Zalcitabine is reported as an ingredient of Hivid in the following countries:

  • Bangladesh
  • Lithuania
  • Tunisia
  • Venezuela

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.